论文部分内容阅读
核因子-κB(NF-κB)与肿瘤密切相关,许多研究证实抑制NF-κB的活性可以增强肺癌对放化疗的敏感性。对NF-κB的干预,可能是治疗肺癌的突破口。
Nuclear factor-κB (NF-κB) is closely related to the tumor. Many studies have shown that inhibiting the activity of NF-κB can enhance the sensitivity of radiotherapy and chemotherapy to lung cancer. The intervention of NF-κB may be a breakthrough in the treatment of lung cancer.